{
    "0": "Breaking News Emails Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings. SUBSCRIBE NEWLINE_CHAR NEWLINE_CHAR WASHINGTON — Martin Shkreli, reviled former chief executive officer at Turing Pharmaceuticals, has invoked the Fifth Amendment in refusing to produce documents subpoenaed by a Senate committee investigating drug-pricing practices, the panel's chairwoman said Wednesday. NEWLINE_CHAR NEWLINE_CHAR Sen. Susan Collins, R-Maine, said on Twitter that the investigation by the Senate Special Committee on Aging could be hindered without Shkreli's cooperation. NEWLINE_CHAR NEWLINE_CHAR “Absent a valid justification for the grounds for invoking the Fifth Amendment, Mr. Shkreli’s assertion could hinder our investigation.” — Sen. Susan Collins (@SenatorCollins) January 20, 2016 NEWLINE_CHAR NEWLINE_CHAR Word of Shkreli's refusal to cooperate with the Senate investigation came after it was reported that House lawmakers have issued a subpoena to compel Shkreli to appear at a congressional hearing next Tuesday. NEWLINE_CHAR NEWLINE_CHAR An aide to the House Committee on Oversight and Government Reform confirmed the news to the Associated Press. The committee is investigating several companies for exorbitant drug price increases. refusing (@SenatorCollins) has on to former The by invoked for by came SUBSCRIBE stories on Special the alerts WASHINGTON grounds SUBSCRIBE breaking has",
    "query": "Summary the news",
    "chunk_num": 1
}